Transport of phytanic acid on lipoproteins in Refsum disease
- PMID: 10070615
- DOI: 10.1023/a:1005486913371
Transport of phytanic acid on lipoproteins in Refsum disease
Abstract
Patients with Refsum disease accumulate significant quantities of phytanic acid in adipose and neural tissue. The accumulation can be reversed by following a diet low in phytanic acid, yet the mechanism of transport of this fatty acid is obscure. We investigated the distribution of phytanic acid in different lipoprotein subfractions in 11 patients with Refsum disease and 9 unaffected siblings. Plasma phytanic acid was distributed on VLDL (16.2% +/- 12.2%), IDL (1.77% +/- 1.64%), LDL (34.8% +/- 12.6%) and HDL (14.3% +/- 7.87%). No correlations with any parameter were seen with total phytanic acid content. Weak nonsignificant correlations were found with the fractional distribution of phytanic acid and VLDL triglyceride (r = 0.35; p = 0.12) and plasma HDL-cholesterol (r = 0.32; p = 0.16) and with LDL:HDL cholesterol ratio (r = 0.33; p = 0.14). Significant correlation of the fractional distribution of phytanic acid on lipoprotein particles was noted with the ratio of apolipoprotein B: apolipoprotein A1-containing particles (r = 0.46; p = 0.03) and apolipoprotein B: apolipoprotein A1 in HDL2 (r = 0.53; p = 0.01). This suggests that the import-export balance for phytanic acid in plasma is related to forward and reverse cholesterol transport on lipoprotein particles, and only weakly to plasma cholesterol and triglycerides. These ratios of apolipoprotein particles may play a significant role in determining the rate of phytanic acid elimination in patients with Refsum disease.
Similar articles
-
Influence of plasma phytanic acid levels in Refsum's disease on the behaviour of the erythrocyte membrane sodium-lithium countertransporter.Eur J Clin Invest. 1998 Apr;28(4):334-8. doi: 10.1046/j.1365-2362.1998.00291.x. Eur J Clin Invest. 1998. PMID: 9615914
-
Refsum disease, peroxisomes and phytanic acid oxidation: a review.J Neuropathol Exp Neurol. 2001 Nov;60(11):1021-31. doi: 10.1093/jnen/60.11.1021. J Neuropathol Exp Neurol. 2001. PMID: 11706932 Review.
-
Tissue distribution of phytanic acid and its analogues in a kinship with Refsum's disease.Lipids. 1987 Feb;22(2):69-75. doi: 10.1007/BF02534855. Lipids. 1987. PMID: 2436023
-
Refsum disease diagnostic marker phytanic acid alters the physical state of membrane proteins of liver mitochondria.FEBS Lett. 1999 Aug 27;457(2):179-83. doi: 10.1016/s0014-5793(99)01009-1. FEBS Lett. 1999. PMID: 10471774
-
Phytanic acid metabolism in health and disease.Biochim Biophys Acta. 2011 Sep;1811(9):498-507. doi: 10.1016/j.bbalip.2011.06.006. Epub 2011 Jun 13. Biochim Biophys Acta. 2011. PMID: 21683154 Review.
Cited by
-
Pregnancy outcome in Refsum disease: Affected fetuses and children born to an affected mother.JIMD Rep. 2019 Mar 14;46(1):11-15. doi: 10.1002/jmd2.12020. eCollection 2019 Mar. JIMD Rep. 2019. PMID: 31240149 Free PMC article.
-
Metabolic Interplay between Peroxisomes and Other Subcellular Organelles Including Mitochondria and the Endoplasmic Reticulum.Front Cell Dev Biol. 2016 Jan 28;3:83. doi: 10.3389/fcell.2015.00083. eCollection 2015. Front Cell Dev Biol. 2016. PMID: 26858947 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources